These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 11248089)

  • 1. Müllerian Inhibiting Substance lowers testosterone in luteinizing hormone-stimulated rodents.
    Trbovich AM; Sluss PM; Laurich VM; O'Neill FH; MacLaughlin DT; Donahoe PK; Teixeira J
    Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3393-7. PubMed ID: 11248089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Müllerian inhibiting substance blocks the protein kinase A-induced expression of cytochrome p450 17alpha-hydroxylase/C(17-20) lyase mRNA in a mouse Leydig cell line independent of cAMP responsive element binding protein phosphorylation.
    Laurich VM; Trbovich AM; O'Neill FH; Houk CP; Sluss PM; Payne AH; Donahoe PK; Teixeira J
    Endocrinology; 2002 Sep; 143(9):3351-60. PubMed ID: 12193547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Müllerian inhibiting substance inhibits testosterone synthesis in adult rats.
    Sriraman V; Niu E; Matias JR; Donahoe PK; MacLaughlin DT; Hardy MP; Lee MM
    J Androl; 2001; 22(5):750-8. PubMed ID: 11545286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Müllerian-inhibiting substance regulates androgen synthesis at the transcriptional level.
    Teixeira J; Fynn-Thompson E; Payne AH; Donahoe PK
    Endocrinology; 1999 Oct; 140(10):4732-8. PubMed ID: 10499532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of steroidogenesis in Leydig cells by Müllerian-inhibiting substance.
    Fynn-Thompson E; Cheng H; Teixeira J
    Mol Cell Endocrinol; 2003 Dec; 211(1-2):99-104. PubMed ID: 14656482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroidogenic activities in MA-10 Leydig cells are differentially altered by cAMP and Müllerian inhibiting substance.
    Trbovich AM; Martinelle N; O'Neill FH; Pearson EJ; Donahoe PK; Sluss PM; Teixeira J
    J Steroid Biochem Mol Biol; 2004 Oct; 92(3):199-208. PubMed ID: 15555913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Müllerian-inhibiting substance inhibits rat Leydig cell regeneration after ethylene dimethanesulphonate ablation.
    Salva A; Hardy MP; Wu XF; Sottas CM; MacLaughlin DT; Donahoe PK; Lee MM
    Biol Reprod; 2004 Mar; 70(3):600-7. PubMed ID: 14585814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pubertal and adult Leydig cell function in Mullerian inhibiting substance-deficient mice.
    Wu X; Arumugam R; Baker SP; Lee MM
    Endocrinology; 2005 Feb; 146(2):589-95. PubMed ID: 15514087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mullerian inhibiting substance recruits ALK3 to regulate Leydig cell differentiation.
    Wu X; Zhang N; Lee MM
    Endocrinology; 2012 Oct; 153(10):4929-37. PubMed ID: 22872577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Müllerian-inhibiting substance type II receptor expression and function in purified rat Leydig cells.
    Lee MM; Seah CC; Masiakos PT; Sottas CM; Preffer FI; Donahoe PK; Maclaughlin DT; Hardy MP
    Endocrinology; 1999 Jun; 140(6):2819-27. PubMed ID: 10342873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between müllerian inhibiting substance and androgens in boys with hypospadias.
    Austin PF; Siow Y; Fallat ME; Cain MP; Rink RC; Casale AJ
    J Urol; 2002 Oct; 168(4 Pt 2):1784-8; discussion 1788. PubMed ID: 12352359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of luteinizing hormone (LH) and androgen on steady state levels of messenger ribonucleic acid for LH receptors, androgen receptors, and steroidogenic enzymes in rat Leydig cell progenitors in vivo.
    Shan L; Hardy DO; Catterall JF; Hardy MP
    Endocrinology; 1995 Apr; 136(4):1686-93. PubMed ID: 7895679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feedback inhibition of steroidogenic acute regulatory protein expression in vitro and in vivo by androgens.
    Houk CP; Pearson EJ; Martinelle N; Donahoe PK; Teixeira J
    Endocrinology; 2004 Mar; 145(3):1269-75. PubMed ID: 14630719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Müllerian inhibiting substance production and cleavage is modulated by gonadotropins and steroids.
    Kuroda T; Lee MM; Ragin RC; Hirobe S; Donahoe PK
    Endocrinology; 1991 Dec; 129(6):2985-92. PubMed ID: 1954882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-1 inhibits Leydig cell steroidogenesis primarily by decreasing 17 alpha-hydroxylase/C17-20 lyase cytochrome P450 expression.
    Hales DB
    Endocrinology; 1992 Nov; 131(5):2165-72. PubMed ID: 1425417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression.
    Clarke TR; Hoshiya Y; Yi SE; Liu X; Lyons KM; Donahoe PK
    Mol Endocrinol; 2001 Jun; 15(6):946-59. PubMed ID: 11376113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ginkgo biloba extract enhances testosterone synthesis of Leydig cells in type 2 diabetic rats].
    Wu XY; Wang WY; Wang RR; Xie L; Fang ZX; Chen GR
    Zhonghua Nan Ke Xue; 2008 Apr; 14(4):371-6. PubMed ID: 18481435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lead affects steroidogenesis in rat Leydig cells in vivo and in vitro.
    Thoreux-Manlay A; Le Goascogne C; Segretain D; Jégou B; Pinon-Lataillade G
    Toxicology; 1995 Nov; 103(1):53-62. PubMed ID: 8525490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of testicular P-450 cholesterol side-chain cleavage and P-450 C17-20 lyase/C17 hydroxylase enzymes in the neonatal and adult rat.
    Lu Y; McDonough A; Farley RA; Warren DW
    Acta Endocrinol (Copenh); 1991 Apr; 124(4):449-54. PubMed ID: 2031442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid hormone and follicle-stimulating hormone regulate Müllerian-inhibiting substance messenger ribonucleic acid expression in cultured neonatal rat Sertoli cells.
    Arambepola NK; Bunick D; Cooke PS
    Endocrinology; 1998 Nov; 139(11):4489-95. PubMed ID: 9794457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.